Professional background

Dr Wilson is a senior consultant neurologist who joined the MS team at the National Hospital for Neurology and Neurosurgery in 2020, after working as a general neurologist and MS specialist at the Royal Free NHS Foundation Trust for 16 years. She has experience in managing all aspects of Multiple Sclerosis including all of the licensed disease-modifying therapies, and is committed to MS service development and optimisation.

She graduated from Guy's Hospital Medical School in 1990 and undertook her Neurology specialist training in London (King's College Hospital, NHNN and the Royal Free Hospital). She has a PhD in Neuro-immunology from Cambridge University and has an ongoing interest in the immunopathology of MS. She is nationally recognised in the field of MS and reglarly speaks on the topic at national and local levels.

Research interests

  • Repair and remyelination mechanisms in MS
  • Immunopathology of MS
  • Neuro-pharmacology.


Drugs in Neurology. Editors. Sathiji Nageshwaran, David Ledingham, Heather C Wilson. Oxford University Press 2016. ISBN 978-0-19-966436-8 2nd Edition in process

Lecture Notes in Neurology 9th edition. Ginsberg L. 2019. ISBN 978-1-40-517722-1 – Wilson HC contributor; Multiple Sclerosis chapter

Early-Onset Dementia: A multidisciplinary approach. Ed. John R Hodges. Chapter 17 Inflammatory and infective disorders. Heather C Wilson and Neil Scolding. Oxford University Press 2001. ISBN 0-19-263034-2

Validating the Portal Population of the United Kingdom Multiple Sclerosis Register. Middleton RM, Rodgers WJ, Chataway J, Schmierer K, Rog D, Galea I, Akbari A, Tuite-Dalton K, Lockhart-Jones H, Griffiths D, Noble DG, Jones KH, Al-Din A, Craner M, Evangelou N, Harman P, Harrower T, Hobart J, Husseyin H, Kasti M, Kipps C, McDonnell G, Owen C, Pearson O, Rashid W, Wilson HC, Ford DV. Mult Scler Relat Disord. 2018 Aug; 24; 3-10

Urinary tract infection in Multiple Sclerosis: closing an audit loop by co-design and innovation. Porter B, John NA, Brenner R, Wilson HC, Turner B, Chataway J. Br J Neurosci Nursing 2019; 15(1); 20-27

Analysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia. Lynch DS, Zhang WJ, Lakshmanan R, Kinsella JA, Uzun GA, Karbay M, Tüfekçioglu Z, Hanagasi H, Burke G, Foulds N, Hammans SR, Bhattacharjee A, Wilson H, Adams M, Walker M, Nicoll JA, Chataway J, Fox N, Davagnanam I, Phadke R, Houlden H. JAMA Neurol 2016; 73(12); 1433-39

The reversible cerebral vasoconstriction syndrome in association with venlafaxine and methenamine. Davies G, Wilson H, Wilhelm T, Bowler J. BMJ Case Reports 2013

Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. Wilson HC, Scolding NJ, Raine CS. J Neuroimmunol 2006; 176 (1-2); 162-73

Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Pitt D, Nagelmeier IE, Wilson HC, Raine CS. Neurology 2003; 61(8); 1113-20

Human oligodendrocyte precursor cells in vitro: phenotypic analysis and differential response to growth factors. Wilson HC, Onischke C, Raine CS. Glia 2003; 44(2); 153-65

The recognition, diagnosis and management of cerebral vasculitis: a European survey. Scolding NJ, Wilson H, Hohlfeld R, Polman C, Leite I, Gilhus N; EFNS Cerebral Vasculitis Task Force. Eur J Neurol. 2002 Jul; 9(4): 343-7

Successful treatment of IgM paraproteinaemic neuropathy with fludarabine. Wilson HC, Lunn MP,
Schey S, Hughes RA. JNNP 1999; 66(5); 575-80